In the current study, we found that genetic polymorphisms in ERAP1 and ERAP2 genes might be associated with CIN and cervical cancer, and suggested that polymorphisms in key antigen-processing genes could affect susceptibility of cervical cancer. This evidence concerns the gene ERAP2 and cervical cancer.